IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Operating cash flow 2016–2025
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$302.4MFY2025 · since FY2016: -$32.7M → -$302.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$302.4M | +14.3% |
| FY2024 | -$353.0M | +2.4% |
| FY2023 | -$361.8M | -23.6% |
| FY2022 | -$292.8M | -28.4% |
| FY2021 | -$227.9M | -11.1% |
| FY2020 | -$205.1M | -29.1% |
| FY2019 | -$158.9M | -56.9% |
| FY2018 | -$101.2M | -28.6% |
| FY2017 | -$78.7M | -140.9% |
| FY2016 | -$32.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IOVA financial trends
IOVA RevenueIOVA Net incomeIOVA Net marginIOVA Gross profitIOVA Gross marginIOVA Operating incomeIOVA Operating marginIOVA Free cash flowIOVA Capital expendituresIOVA Return on equityIOVA Stock buybacksIOVA Dividends paidIOVA Total assetsIOVA Total liabilitiesIOVA Shareholders’ equityIOVA overview →